Back to Top Skip to main content Skip to sub-navigation

COVID 19 Vaccine Is Now Available for Children 5 to 11

Image of 5-year-old girl in mask reads a book by herself. Karina Melendez, 5, reads a book in the reading corner of a Fort Bliss Child Development Center, Aug. 10, 2020. Now, the Pfizer-BioNTech vaccine for 5 through11 year olds has been authorized and is being offered to protect this age group against COVID-19.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

The Military Health System is poised to offer COVID-19 vaccinations to children ages 5 through 11 years following issuance of an Emergency Use Authorization (EUA) to Pfizer-BioNTech for its COVID-19 vaccine by the Food and Drug Administration (FDA).

The move will boost the military community's defenses against a possible surge of COVID-19 as winter approaches and ease the worries of parents weary of the pandemic and its effects on children and their schooling.

"This will help protect the whole family and slow the spread of COVID-19 in your community and household," said Amy Swarthout-Ebarb, a clinical nurse educator for the Defense Health Agency's Immunization Healthcare Division (DHA-IHD) in San Antonio, Texas.

"For families, parents and older siblings have received the vaccine. The younger ones are just waiting," she said.

The new pediatric vaccine is important "because children 5-11 can still transmit the COVID-19 virus, potentially affecting those who are not vaccinated and are at risk," Swarthout-Ebarb said.

There are nearly 1 million children 5 through11 years of age who are eligible to receive the COVID-19 vaccine from the Defense Department, according to Air Force Col. (Dr.) Tonya Rans, chief of the DHA-IHD.

On Nov. 2, Pfizer-BioNTech's 5 through 11 year old COVID-19 vaccine product was recommended by the Centers for Disease Control and Prevention as a safe and effective option for children.

There is no Defense Department requirement for children within the Military Health System to get a COVID-19 vaccine. Military health officials are encouraging parents to talk with their health care providers about any questions or concerns they may have about this vaccine.

"The providers are the best people to give advice to parents," said Dr. David Hrncir, medical director, Central Vaccine Safety Hub, DHA-IHD.

"Pediatricians are good at this and will present the COVID-19 vaccine as just another vaccine" that children should take, he said.

Medical experts say the benefits of administering the vaccine to children to protect against COVID-19 outweigh the possible increased risk of the rare side effect called myocarditis, or an inflammation of the heart muscle.

Five to 11 year-olds rarely report problems with vaccines, Hrncir said.

Pediatric doses

The Pfizer-BioNTech vaccine dose for children is one-third smaller than the adult version, at 10 mcg versus the 30 mcg dose for those 12 years and older. The vaccine for children is given as two doses three weeks apart, a two-step sequence similar to the adult version.

Pfizer studied approximately 3,100 children ages 5 to 11 in clinical trials. The 10 mcg dose was carefully selected as the preferred dose for safety, tolerability and immunogenicity in children 5 to 11 years of age, according to the company.

The vaccines are also packaged differently to help differentiate the adult doses from the pediatric version.

The vaccine intended for people ages 12 and up has a purple or gray cap and label for adults and adolescents. To distinguish between the vaccines, the pediatric version, for children ages 5 through 11 years, has an orange label and cap.

For now, Pfizer-BioNTech offers the only FDA-authorized COVID-19 vaccine for those 5 through 11 years. Other pharmaceutical companies may seek approval for this age group in the future.

You also may be interested in...

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus
Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: November 17, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.